Pharmacokinetic Study to Investigate the Bioavailability and Tolerability of 3 Oral Formulations of Sodium Thiosulfate

NCT02624479 · clinicaltrials.gov ↗
PHASE1
Phase
WITHDRAWN
Status
OTHER
Sponsor class

Stopped Formulations could never be successfully produced

Conditions

Interventions

Sponsor

Insel Gruppe AG, University Hospital Bern